Evaluation of the gastric behaviour of coevaporate particles under fasting and non-fasting conditions

International Journal of Pharmaceutics

Volumn 123, Issue 1, 1995, Pages 145-147

  Beten, D B ^a   Van Gansbeke, B ^b   Schoutens, A ^b   Moes A J ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

111In oxinate; Coevaporate; Eudragit S; Gamma scintigraphy; Gastric emptying; Pellet

Indexed keywords

8 QUINOLINOL INDIUM IN 111; EUDRAGIT;

CLINICAL TRIAL; DENSITY; DISPERSION; FOOD INTAKE; GAMMA SCINTIGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PRIORITY JOURNAL; SHORT SURVEY; SOLID; STOMACH EMPTYING; VOLUNTEER;

EID: 0029056182     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)00087-Y     Document Type: Article

References (16)

1. Controlled-release coevaporates of dipyridamole prepared with acrylic polymers
2. The use of gamma scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations
3. Comparative gastrointestinal transit of pellet systems of varying density
4. Gastrointestinal transit of pellets of differing size and density
5. Do pellet formulations empty from the stomach with food?
6. A comparative study of the gastrointestinal transit of a pellet and tablet formulations
7. The effect of food on the gastrointestinal transit of pellets and an osmotic device (Osmet)
8. The effect of density on the gastric emptying of single- and multiple-unit dosage forms
9. The influence of density on the gastrointestinal transit of pellets
10. Comparison of left anterior oblique, anterior and geometric mean methods for determining gastric emptying times
11. Drug delivery to the proximal colon
12. Applications of solid dispersions with enteric coating agents to overcome some pharmaceutical problems
13. The influence of food on the gastric emptying of multiparticulate dosage forms
14. Sustained-release solid dispersions of indomethacin with Eudragit RS and RL
15. Gastrointestinal transit of non-disintegrating solid formulations in humans
16. Gastrointestinal transit and absorption of theophylline from a multiparticulate controlled-release formulation